CLGN
$0.60
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.
Recent News
When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Turn A Profit?
We feel now is a pretty good time to analyse CollPlant Biotechnologies Ltd.'s ( NASDAQ:CLGN ) business as it appears...
CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering
CollPlant (CLGN) Biotechnologies announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 1.6M of the company’s ordinary shares at a purchase price of $1.25 per share in a registered direct offering. In addition, in a concurrent private placement, the company will issue unregistered series A warrants to purchase up to 1.6M ordinary shares and unregistered series B warrants to purchase up to 1.6M ordinary shares. The series A warrants will have an exe
Here's Why We're A Bit Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, although...
One CollPlant Biotechnologies Insider Raised Their Stake In The Previous Year
From what we can see, insiders were net buyers in CollPlant Biotechnologies Ltd.'s ( NASDAQ:CLGN ) during the past 12...
Discover May 2025's Top Penny Stocks
Over the last 7 days, the U.S. market has risen by 1.2%, contributing to a 12% increase over the past year, with earnings anticipated to grow by 14% annually. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever; these stocks can provide a mix of affordability and growth potential when paired with strong financials. Below, we'll explore three penny stocks that stand out for their financial strength and resilience in today's...